View Larger Map | Get Directions
Dr. James Mohler responds to new research that supports active surveillance for low-risk prostate cancer; discourages overtreatment.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
